[{"address1": "Jalan Prima Tropika Barat 2,", "address2": "Lot 1 to 3 Taman Prima Tropika", "city": "Seri Kembangan", "zip": "43300", "country": "Malaysia", "phone": "603 8949 3199", "fax": "603 8949 3198", "website": "https://www.ipatherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ImmunoPrecise Antibodies Ltd. operates as a AI-driven biotherapeutic research and technology company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies. The company's contract research organizations services include B cell Select platforms that enable antibody screening directly from B cells, facilitating the analysis of a set of antibodies, as well as for screening compared to traditional technologies; phage display services that are based on building custom immune libraries from various species; DeepDisplay, a technology utilizing a combination of transgenic animal platforms; bispecific Abthena technology; antibody humanization services; affinity maturation services; antibody development services; protein manufacturing; and cell line development services of target proteins or antibodies. It is also involved in the development and licensing of antibody discovery platforms and related IP assets. The company was founded in 1983 and is based in Seri Kembangan, Malaysia.", "fullTimeEmployees": 81, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jennifer Lynne Bath Ph.D.", "title": "CEO, President & Non-Independent Director", "fiscalYear": 2025, "totalPay": 632870, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dirk Van Hyfte M.D., Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frederic  Chabot", "title": "Head of Corporate Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ingrid  Brands M.D., Ph.D.", "title": "Chief Innovation & Strategy Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.66, "open": 1.6, "dayLow": 1.52, "dayHigh": 1.64, "regularMarketPreviousClose": 1.66, "regularMarketOpen": 1.6, "regularMarketDayLow": 1.52, "regularMarketDayHigh": 1.64, "payoutRatio": 0.0, "beta": 0.462, "forwardPE": -10.25, "volume": 991092, "regularMarketVolume": 991092, "averageVolume": 2445585, "averageVolume10days": 1724560, "averageDailyVolume10Day": 1724560, "bid": 1.6, "ask": 1.57, "bidSize": 1, "askSize": 1, "marketCap": 75692720, "fiftyTwoWeekLow": 0.27, "fiftyTwoWeekHigh": 2.41, "priceToSalesTrailing12Months": 3.0869787, "fiftyDayAverage": 1.19546, "twoHundredDayAverage": 0.63306, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 78430752, "profitMargins": -1.23303, "floatShares": 41947170, "sharesOutstanding": 46154100, "sharesShort": 495801, "sharesShortPriorMonth": 1390071, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0108, "heldPercentInsiders": 0.09066, "heldPercentInstitutions": 0.08653, "shortRatio": 0.23, "shortPercentOfFloat": 0.0109, "impliedSharesOutstanding": 45765100, "bookValue": 0.512, "priceToBook": 3.2031248, "lastFiscalYearEnd": 1745971200, "nextFiscalYearEnd": 1777507200, "mostRecentQuarter": 1745971200, "netIncomeToCommon": -30234000, "trailingEps": -0.66, "forwardEps": -0.16, "lastSplitFactor": "1:5", "lastSplitDate": 1606089600, "enterpriseToRevenue": 3.199, "enterpriseToEbitda": -8.423, "52WeekChange": 1.0197043, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 1.64, "targetHighPrice": 5.0, "targetLowPrice": 3.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 10665000, "totalCashPerShare": 0.231, "ebitda": -9312000, "totalDebt": 13403000, "quickRatio": 1.717, "currentRatio": 2.081, "totalRevenue": 24520000, "debtToEquity": 56.73, "revenuePerShare": 0.734, "returnOnAssets": -0.14814, "returnOnEquity": -1.01963, "grossProfits": 13548000, "freeCashflow": -2613125, "operatingCashflow": -6410000, "revenueGrowth": 0.081, "grossMargins": 0.55253, "ebitdaMargins": -0.37977, "operatingMargins": -0.21114, "financialCurrency": "CAD", "symbol": "IPA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "ImmunoPrecise Antibodies Ltd.", "shortName": "ImmunoPrecise Antibodies Ltd.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1010413800000, "postMarketChangePercent": -1.82927, "postMarketPrice": 1.61, "postMarketChange": -0.03, "regularMarketChange": -0.02, "regularMarketDayRange": "1.52 - 1.64", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2445585, "fiftyTwoWeekLowChange": 1.37, "fiftyTwoWeekLowChangePercent": 5.074074, "fiftyTwoWeekRange": "0.27 - 2.41", "fiftyTwoWeekHighChange": -0.7700001, "fiftyTwoWeekHighChangePercent": -0.31950212, "fiftyTwoWeekChangePercent": 101.970436, "dividendDate": 1606089600, "earningsTimestamp": 1753792200, "earningsTimestampStart": 1758025800, "earningsTimestampEnd": 1758025800, "earningsCallTimestampStart": 1753799400, "earningsCallTimestampEnd": 1753799400, "regularMarketChangePercent": -1.20482, "regularMarketPrice": 1.64, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.66, "epsForward": -0.16, "fiftyDayAverageChange": 0.44454002, "fiftyDayAverageChangePercent": 0.3718569, "twoHundredDayAverageChange": 1.00694, "twoHundredDayAverageChangePercent": 1.5905918, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1754092724, "regularMarketTime": 1754078402, "exchange": "NCM", "messageBoardId": "finmb_406475483", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "ImmunoPrecise Antibodies", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]